Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Kay

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Archives of General Psychiatry|August 1, 1983
LSD psychosis or LSD-induced schizophrenia? A multimethod inquiryM M Vardy, S R Kay
Comprehensive Psychiatry|March 1, 1990
Predicting outcome of schizophrenia: significance of symptom profiles and outcome dimensionsS R Kay, L M Murrill
Psychiatric Developments|January 1, 1987
The positive-negative dimension in schizophrenia: its validity and significanceS R Kay, L A Opler
Psychopharmacologia|August 21, 1975
A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differencesM M Singh, S R Kay
Biological Psychiatry|February 1, 1979
Cognitive abnormality in schizophrenia: a dual-process modelS R Kay, M M Singh
Psychiatry|August 1, 1982
The therapeutic value of psychotherapists' values and therapy orientationsM M Vardy, S R Kay
International Journal of Psychiatry in Medicine|January 1, 1985
L-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental studyS R Kay, L A Opler
Neuropsychobiology|January 1, 1979
Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological modelM M Singh, S R Kay
Comprehensive Psychiatry|January 1, 1991
Stability of psychopathology dimensions in chronic schizophrenia: response to clozapine treatmentS R Kay, J P Lindenmayer
Perceptual and Motor Skills|December 1, 1973
Critical study of the Organic Integrity Test as a diagnostic and therapeutic index in schizophreniaS R Kay, R G Gang
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Archives of General Psychiatry|August 1, 1983
LSD psychosis or LSD-induced schizophrenia? A multimethod inquiryM M Vardy, S R Kay
Comprehensive Psychiatry|March 1, 1990
Predicting outcome of schizophrenia: significance of symptom profiles and outcome dimensionsS R Kay, L M Murrill
Psychiatric Developments|January 1, 1987
The positive-negative dimension in schizophrenia: its validity and significanceS R Kay, L A Opler
Psychopharmacologia|August 21, 1975
A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differencesM M Singh, S R Kay
Biological Psychiatry|February 1, 1979
Cognitive abnormality in schizophrenia: a dual-process modelS R Kay, M M Singh
Psychiatry|August 1, 1982
The therapeutic value of psychotherapists' values and therapy orientationsM M Vardy, S R Kay
International Journal of Psychiatry in Medicine|January 1, 1985
L-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental studyS R Kay, L A Opler
Neuropsychobiology|January 1, 1979
Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological modelM M Singh, S R Kay
Comprehensive Psychiatry|January 1, 1991
Stability of psychopathology dimensions in chronic schizophrenia: response to clozapine treatmentS R Kay, J P Lindenmayer
Perceptual and Motor Skills|December 1, 1973
Critical study of the Organic Integrity Test as a diagnostic and therapeutic index in schizophreniaS R Kay, R G Gang
Pageof 12